|
Dr. Frank S. Pidcock is a research scientist at Kennedy Krieger Institute. He is also Associate Professor of Physical Medicine and Rehabilitation and Associate Professor of Pediatrics at Johns Hopkins University School of Medicine.
Biographical Sketch:
Dr. Pidcock attended the Johns Hopkins University before going on to medical school at the Hahnemann Medical College in Philadelphia, Pennsylvania, from which he graduated in 1977. His postdoctoral training includes pediatric residency at Hahnemann University Hospital from 1979 to 1981, developmental pediatrics fellowship at St. Christopher's Hospital for Children from 1979 to 1981, and rehabilitation medicine residency at Thomas Jefferson University Hospital from 1991 to 1994. Dr. Pidcock was the director of the pediatrics program at Children's Rehabilitation Hospital in Philadelphia from 1987 until 1991. After completing a residency in rehabilitation medicine in 1994, Dr. Pidcock joined the medical staff at the Kennedy Krieger Institute as the Associate Director of the Pediatric Rehabilitation Program. Dr. Pidcock is an attending physician at both Johns Hopkins Hospital and Kennedy Krieger Children's Hospital. He is board certified in Physical Medicine and Rehabilitation, Pediatric Rehabilitation Medicine, and Pediatrics.
Research Summary:
Dr. Pidcock’s clinical research focuses on developing treatment protocols and quantitative measurements for the use of therapeutic botulinum toxin injections in the treatment of children with spasticity from cerebral palsy, traumatic brain injury, or other processes that affect motor control. Indications for giving therapeutic botulinum toxin include improving mobility, preventing deformity, and improving quality of life. Measurement techniques that Dr. Pidcock is studying include functional brain imaging (fMRI) to look at the effects of peripheral botulinum toxin injections on cortical activation and a spasticity measurement system designed to quantitatively measure the effects of spasticity reduction at the wrist.
Other areas of interest for Dr. Pidcock include the rehabilitation of children with pediatric transverse myelitis and musculo-skeletal manifestations of chronic graft vs. host disease. He is also involved with the development of outcome measurement tools for children with burns.
Recent Publications/Presentations:
Pidcock FS. The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy. J Pediatr. 2004 Aug;145(2 Suppl):S33-5.
Kanda T, Pidcock FS, Hayakawa K, Yamori Y, Shikata Y. Motor outcome differences between two groups of children with spastic diplegia who received different intensities of early onset physiotherapy followed for five years. Brain & Development; 26: 118-126, 2004.
Pidcock FS, Fauerbach JA, Ober M, Carney J. The Rehabilitation/School Matrix: A model for accommodating the noncompliant child with severe burns. Journal of Burn Care & Rehabilitation; 24: 342-346, 2003.
Barnes G, Benjamin S, Bowen JD, ..., Pidcock FS, et al: Proposed Diagnostic Criteria and Nosology of Acute Transverse Myelitis. Neurology 2002; 59:499-505.
Kazis LE, Liang, MH, Lee A , ... , Pidcock F, et al. : The Development, Validation and Testing of a Health Outcomes Burn Questionnaire for Infants and Children. Journal of Burn Care and Rehabilitation 2002; 23: 196-207
Pidcock FS, Wise JM, Christensen JR: Treatment of Severe Post-Traumatic Bruxism with Botulinum Toxin-A: Case Report. Journal of Oral and Maxillofacial Surgery; 60: 117-120, 2002
Daltroy LH, Liang MH, Phillips CB, ..., Pidcock FS, et al. American Burn Association/Shriners Hospitals for Children Burn Outcomes Questionnaire: Construction and Psychometric Properties. J Burn Care Rehabil, 21:29-39, 2000. | 